β-Glucan treatment reduces morbidity & mortality in Influenza A virus (IAV) infection though enhanced neutrophil recruitment via RoRγt+ T cells & type I IFN-driven granulopoiesis, generating a unique subset of IL-10-producing neutrophils.

#TrainedImmunity #β-Glucan #Neutrophils #InfluenzaA

🧵 (1/7)